In the rapidly evolving landscape of biochemical research, few topics have generated as much intrigue as the Elabela peptide. Often referred to in scientific literature by various aliases such as Apela or Toddler, this molecule has fundament by YR Liu·2023·Cited by 10—ELABELA(ELA), also known as Toddler or Apela, is a novel endogenous ligand of the angiotensin receptor AT1-related receptor protein (APJ). ally changed our understanding of signaling pathways. As someone deeply interested in the mechanics of cellular biology and peptide science, I have spent considerable time by SC Chng·2013·Cited by 592—Our results reveal the existence of a peptide hormone,ELA, which, together with APLNR, forms an essential signaling axis for early cardiovascular development.Read more analyzing the data surrounding this fascinating hormonal peptide.
Understanding Elabela Peptide: The Basics
At its core, Elabela (often abbreviated as ELA) is recognized as the second endogenous ligand for the Apelin receptor. While the Apelin system has been studied for y by A Li·2025—Elabela (ELA) is a relatively newly identified bioactive micropeptide that functions as the second endogenous ligand for the apelin receptor (APJ). ears, the discovery of Elabela provided a missing piece to a complex puzzle. It is a peptide that functions as a signaling molecule, effectively acting as a body-own peptide hormone class that modulates various physiological responses.
When we look at Elabela (ELA) in the context Apelins, ELABELA, and their derivatives: Peptidic of the APLNR gene and the broader apelinergic system, it becomes clear why researchers are so captivated. Apelin and Elabela are endogenous peptide ligands that interact with the APJ receptor—a G protein-coupled receptor (GPCR) that is widely expressed across different tissues. Because it is a hormone peptide belonging to the adipokine group, its influence extends far beyond a single organ system.
Key Structural Variations and Research Fragments
For those looking into specific laboratory applications, the structural diversity of this molecule is significan 10 a novel peptide elabela is associated with hypertension t. One of the most common forms discussed in literature is ELA-32 (human). This is a potent, high-affinity agonist for the apelin receptor, with specific binding constants (IC50 = 0.27 nM; Kd = 0.51 nM) that highlight its biological activity.
Beyond the full-length hormone, researchers frequently utilize shorter, active segments. For instance, Elabela(19-32) is an active fragment of the parent molecule. ELA(19-32), also known as Elabela(19-32) TFA, is frequently studied for its ability to activate specific pathways, such as Gαi1 and β-arrestin-2 signaling. These fragments are essential for mapping out how elabela regulates cardiac and vascular function in adults, providing insights into how these signals are transduced at the cellular level.
Physiological Significance and E by B LaFlamme·2014·Cited by 4—ELABELA, a peptide hormone for heart development You have full access to this article via your institution. Download PDF.Read more merging Research
The discovery of Elabela has provided a new lens through which we view systemic homeostasis. It was originally identified as a critical cardiac developmental peptide, playing a vital role in the early stages of heart and vascular formation in embryonic models.
Recent studies have expanded this scope significantly:
* Neuroprotective Potential: Some research indicates that ELA could alleviate neuronal apoptosis and axonal damage by influencing specific signaling pathways like CTDSP1/AKT.
* Diagnostic Markers: There is growing interest in how ELA can be used as a diagnostic marker for CVDs, given its role in reducing oxidative stress and tissue fibrosis.
* Oncology and Growth: Elabela is a new player in tumor progression and cancer invasion, acting as a proangiogenic molecule that warrants further investigation into its complex, dual-natured effects on cell proliferation.
Why the Apelinergic System Matters
The APJR agonist activity associated with ELABELA is not merely academic. Because it is a recently discovered hormone, the scientific community is still mapping the full breadth of its reach. Unlike older, more established p by A Murza·2016·Cited by 155—ELABELA (ELA) was recently discovered as a novel endogenous ligand of the apelin receptor (APJ), a G protein-coupled receptor. eptides, ELABELA offers a unique, nuanced approach to understanding how our bodies maintain fluid balance and vascular tone.
Whether examining the full-length ELA peptide or derivatives like Elabela(19-32), the data consistently points toward a highly specialized mechanism of action. It is this specificity—the ability to act as an endogenous peptide ligand that fine-tunes receptor activity without the broad-spectrum effects of other hormones—that makes it a standout subject in modern biochemical studies.
Final Reflections
My interest in Elabela(19-32) is an active fragmentof ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) activates the Gαi1 and β-arrestin-2 signaling pathways Read more Elabela stems from the sheer elegance of its discovery. From its humble beginnings as a "toddler" gene product essential for heart development to its current status as a molecule with potential diagnostic utility for cardiovascular health, the story of this peptide is far from over. As we continue to uncover how elabela peptide interacts with the APLNR gene and other receptors, we gain a clearer picture of the intricate, microscopic highways that keep our biological systems in balance. For those of us tracking the by P Yang·2017·Cited by 286—Elabela/toddler (ELA) is acritical cardiac developmental peptidethat acts through the G-protein–coupled apelin receptor, despite lack of Read more se developments, the future of this hormonal peptide remains one of the most compelling frontiers in peptide science.